Unsuccessful take over fails to spike Polpharma's hopes off CEE greatness

"Our strategy has not changed. We want to remain a regional player and strengthen our position on the CEE markets. We are negotiating the purchase of a few foreign entities," assured Polpharma president, Jacek Glinka. He went on to say that the company stands a strong chance of carrying out its plans, as it is one of the five largest regional pharmaceutical companies in this part of Europe. It will compete with entities, such as Pliva, KRKA, Gedeon Richter and Zentiva. "We will also boost our export sales, which currently constitute 15% of revenues. Last year it grew 30%, but we intend to achieve even better results," said Glinka. In 2005 the firm will introduce 7-9 new medicines to the market. (Puls Biznesu, pp. 1, 10) M.M.